Form 4: Accendra Health Executive Sells Shares for Tax Withholding

Accendra Health's EVP & CFO, Jonathan A. Leon, reported a transaction involving the surrender of shares to cover tax withholding obligations upon restricted stock vesting.

Summary

• Jonathan A. Leon, EVP & CFO of Accendra Health, Inc., reported a transaction on May 15, 2026.
• The transaction involved the surrender of 1,770 shares of common stock to the issuer.
• These shares were used to satisfy tax withholding obligations related to the vesting of restricted stock.
• The reported price for these shares was $3.04.
• Following this transaction, Mr. Leon beneficially owns 290,533 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard administrative transaction for tax purposes rather than a strategic decision or a reflection of the company's performance.

Positives

• The transaction addresses tax obligations, which is a standard and necessary part of executive compensation.
• The executive continues to hold a significant number of shares (290,533) directly, indicating continued beneficial ownership.

Negatives

• The surrender of shares for tax withholding represents a reduction in the executive's direct shareholding, albeit for a necessary purpose.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions, such as this one involving tax withholding for executive compensation, and are standard practice within the healthcare industry.

Stakeholder Impact

• Shareholders: No immediate impact on share count or company financials, as this is an internal executive compensation matter.
• Employees: Indirectly relates to executive compensation structures.
• Management: Standard procedure for managing tax liabilities associated with equity compensation.

Key Dates

Keywords

Form 4, SEC Filing, Insider Transaction, Accendra Health, Executive Compensation, Tax Withholding, Restricted Stock, Share Surrender